Citadel Advisors
NUVL icon

Citadel Advisors’s Nuvalent NUVL Stock Holding History

Citadel Advisors’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$758K Buy
7,400
+1,700
+30% +$173K ﹤0.01% 8329
2025
Q4 		$573K Sell
5,700
-50,100
-90% -$4.94M ﹤0.01% 8700
2025
Q3 		$4.83M Buy
55,800
+1,700
+3% +$134K ﹤0.01% 4425
2025
Q2 		$4.13M Sell
54,100
-19,300
-26% -$1.41M ﹤0.01% 4440
2025
Q1 		$5.21M Sell
73,400
-14,900
-17% -$1.17M ﹤0.01% 3803
2024
Q4 		$6.91M Sell
88,300
-41,700
-32% -$3.89M ﹤0.01% 3468
2024
Q3 		$13.3M Buy
130,000
+119,000
+1,082% +$9.87M ﹤0.01% 2527
2024
Q2 		$834K Buy
11,000
+4,800
+77% +$341K ﹤0.01% 6969
2024
Q1 		$466K Sell
6,200
-3,500
-36% -$279K ﹤0.01% 8554
2023
Q4 		$714K Sell
9,700
-5,000
-34% -$309K ﹤0.01% 7355
2023
Q3 		$676K Buy
14,700
+14,600
+14,600% +$648K ﹤0.01% 7404
2023
Q2 		$4.22K Buy
+100
New +$3.78K ﹤0.01% 13618
2023
Q1 		– Sell
-1,000
Closed -$29.8K – 15249
2022
Q4 		$29.8K Buy
+1,000
New +$27.9K ﹤0.01% 12764

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors's NUVL Position: Q1 2026 in Review

Citadel Advisors reduced its Nuvalent (NUVL) stake by 15% in Q1 2026, selling an estimated $2.89M and leaving 166,773 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

Citadel Advisors first reported a position in NUVL in Q1 2022 and has held it in 17 quarters since. The position peaked at $24.8M in Q3 2024. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Citadel Advisors held 166,773 shares of Nuvalent worth $17.1M as of Q1 2026.
  • Citadel Advisors sold 28,383 Nuvalent shares in Q1 2026, an estimated $2.89M.
  • Nuvalent made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2521 holding.
  • Citadel Advisors first reported a position in Nuvalent in Q1 2022 and has held it in 17 quarters since.
  • Citadel Advisors's Nuvalent position peaked at $24.8M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.